Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/2012
02/29/2012CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
02/29/2012CN101323649B Method for extracting mushroom polysaccharide by using ultra-high pressure
02/29/2012CN101279081B Chinese medicine for improving microcirculation and immunity of human body and processing method
02/29/2012CA2805767A1 Bacterial ghosts for mediating innate immunity
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124614 Steroidal compounds for inhibiting steroid sulphatase
02/28/2012US8124590 Biodegradable immunomodulatory formulations and methods for use thereof
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124356 Methods of purifying zsig33
02/28/2012US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia
02/28/2012US8124133 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/28/2012US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
02/28/2012US8124074 Fusion proteins
02/28/2012US8124070 Probiotics for pet food applications
02/28/2012US8124066 Methods of using interleukin-2 mutants with reduced toxicity
02/28/2012US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making
02/23/2012WO2012024632A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
02/23/2012WO2012024621A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
02/23/2012WO2012024559A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012WO2012024530A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
02/23/2012WO2012024433A2 Compounds that inhibit tau phosphorylation
02/23/2012WO2012024427A2 Human facilitating cells and uses thereof
02/23/2012WO2012024284A1 Lipidated immune response modifier compound compositions, formulations, and methods
02/23/2012WO2012024196A2 A novel method for creating, suspending and stabilizing electronically modified reaction intermideates
02/23/2012WO2012024161A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012WO2012024150A1 Oxadiazole inhibitors of leukotriene production
02/23/2012WO2012023614A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded
02/23/2012WO2012023301A1 Novel plant-derived immunostimulating agent
02/23/2012WO2012023179A1 Long-acting dermatological antipruritic agent
02/23/2012WO2012022740A1 Combination treatment of multiple sclerosis
02/23/2012WO2012022737A1 Compositions and methods for improved organ transplant preservation and acceptance
02/23/2012WO2012021934A1 Humanized anti-interleukin 3 receptor alpha chain antibodies
02/23/2012WO2011163533A3 One step removal of selected molecules from body fluid and tissue
02/23/2012WO2011139738A9 Therapies using zanolimumab to enhance the immune response
02/23/2012WO2011139488A3 Methods and materials for reducing cardiac xenograft rejection
02/23/2012WO2011116299A3 Myeloid derived suppressor cell inhibiting agents
02/23/2012US20120046366 Extractions of Fixed Oil and Thymoquinone Rich Fractions (TQRF)
02/23/2012US20120046357 Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
02/23/2012US20120046351 Medicinal cannabis added in food
02/23/2012US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046316 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/23/2012US20120046311 Chemokine receptor antagonists and methods of use thereof
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046284 Salts and hydrates of 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(cis-4--cyclohexan-1-yloxy)-7-methoxy-quinazoline, their use as a medicament and the preparation thereof
02/23/2012US20120046278 Thiazolopyrimidine modulators as immunosuppressive agents
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046270 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
02/23/2012US20120046262 Megestrol acetate products, method of manufacture, and method of use
02/23/2012US20120046258 Novel crystalline pharmaceutical product
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046245 Compositions and methods for inhibition of the jak pathway
02/23/2012US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators
02/23/2012US20120046237 Compositions for protection against superficial vasodilator flush syndrome, and methods of use
02/23/2012US20120046218 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045481 Preventive and/or ameliorative agent for diseases, stamina enhancement agent, anti-fatigue agent, and pharmaceutical and food and drink using them
02/23/2012US20120045478 Method and compositions
02/23/2012US20120045477 Method for Treating Cancer with Toxoplasma Gondii Vaccine
02/23/2012US20120045476 Live attenuated mycoplasma strains
02/23/2012US20120045475 Live attenuated vaccines
02/23/2012US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof
02/23/2012US20120045473 Biomolecule Surface Display and Uses Thereof
02/23/2012US20120045472 Biochemically Stabilized HIV-1 ENV Trimer Vaccine
02/23/2012US20120045470 Imatinib immunoassay
02/23/2012US20120045469 Vaccine
02/23/2012US20120045468 Immunogenic Compositions and Uses Thereof
02/23/2012US20120045466 Identification of antigenic peptides from multiple myeloma cells
02/23/2012US20120045462 Inflammation Inhibiting Compounds
02/23/2012US20120045461 Compositions and Methods for Inducing an Immune Response in a Mammal and Methods of Avoiding an Immune Response to Oligonucleotide Agents Such as Short Interfering RNAs
02/23/2012US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045454 2,4-pyrimidinediamine compounds and their uses
02/23/2012US20120045453 Anti-IL-6 Antibodies, Compositions, Methods and Uses
02/23/2012US20120045449 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045441 Methods of treating lung disease and other inflammatory diseases
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045432 B lymphocyte stimulator assays
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012US20120045428 Methods for preparing a fermented ginseng concentrate or powder
02/23/2012US20120045415 Treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin
02/23/2012US20120045414 Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
02/23/2012DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives
02/23/2012CA2808798A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012CA2808624A1 Lipidated immune response modifier compound compositions, formulations, and methods
02/23/2012CA2808307A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012CA2807701A1 Human facilitating cells and uses thereof
02/23/2012CA2807364A1 Oxadiazole inhibitors of leukotriene production
02/23/2012CA2805624A1 Compositions and methods for improved organ transplant preservation and acceptance
02/23/2012CA2805176A1 Humanized anti-interleukin 3 receptor alpha chain antibodies
02/22/2012EP2420833A1 T-cell vaccine
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 1172